The stock price of CVS Health (NYSE: CVS) has seen a rise of 11% over the last month, while it is up 7% over the last ten days. The recent rise can be attributed to its upbeat Q3 results. The company's Q3 revenue of $73.8 billion was up 10% y-o-y and comfortably above our estimate of $70.6 billion..
The stock price of CVS Health (NYSE: CVS) has seen a rise of 11% over the last month, while it is up 7% over the last ten days. The recent rise can be attributed to its upbeat Q3 results. The company's Q3 revenue of $73.8 billion was up 10% y-o-y and comfortably above our estimate of $70.6 billion..
Share this Article
Recommended